First wave of COVID-19 had major impact on regular healthcare and health During the first wave, the novel coronavirus (SARS-CoV-2) had a major impact on healthcare in the Netherlands. Many patients faced delays in appointments and treatments.
Major increase in hospital admissions and ICU admissions due to COVID-19 The increase in the reported number of people who tested positive for COVID-19 in the last two weeks was followed last week by an increase in the number of hospital and ICU admissions.
Increase in newly reported COVID-19 infections is cause for concern 27% more new COVID-19 infections were reported last week than in the week before that.
Possible start of COVID-19 vaccination in early January If all goes well, the first people in the Netherlands will be vaccinated against COVID-19 in early January. The logistics operation aims to start vaccination in the week of 4 January 2021.
Only minor decrease in number of newly reported COVID-19 infections Last week there was a slight decrease in the number of newly reported COVID-19 infections: 33,949 newly reported infections in the past week compared to 36,931 newly reported infections in the week
COVID-19 consequences impact vulnerable groups more in the long term The effects of the corona crisis have a greater impact on vulnerable groups in society, such as lower-educated adults, young people, the elderly and people with underlying health problems.
Compliance with coronavirus measures has improved Autumn 2020 saw a strong surge in the number of people who tested positive for COVID-19.
Drinking water protection files are steadily progressing Local and provincial authorities, drinking water supply companies and water resource managers authority are making progress with the assessment of the current and future risks for the quality of ex
New bacterium in ticks Last year, a man was treated at the Amsterdam Academic Medical Centre (AMC) after being bitten by a tick and becoming infected with a strain of the Borrelia bacterium not previously encountered in
Regional differences in testing rates underestimate incidence of LGV epidemic Until 2003, Lymphogranuloma venereum (LGV), an aggressive form of chlamydia, was considered to be a rare tropical disease, endemic to Africa, Asia and the Caribbean.